RT Journal Article
SR Electronic
T1 Aliskiren-Based Therapy Controls Blood Pressure Regardless of Plasma Renin Activity
JF MD Conference Express
YR 2010
FD SAGE Publications
VO 10
IS 5
SP 7
OP 7
DO 10.1177/155989771005003
UL http://mdc.sagepub.com/content/10/5/7.1.abstract
AB Although aliskiren is established as an effective antihypertensive agent, it is not known whether its BP-lowering effects are dependent on baseline plasma renin activity (PRA) levels. The current prospective, open-label trial was defined to evaluate the ability of aliskiren to control BP alone and in combination with other antihypertensive medications in patients with various baseline PRA levels.